Proteomics Study of Breast Cancer-Derived Small Extracellular Vesicles: Unveiling Potential Cancer Biomarkers

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Small extracellular vesicles (sEVs) are secreted by cells and contain biomolecules reflecting their origin.
• Cancer-derived sEVs show promise as diagnostic biomarkers due to their unique molecular cargo.
• Plasma-derived sEVs offer a non-invasive source for identifying cancer biomarkers.

Purpose of the Study:

• To profile protein expression in plasma-derived sEVs from breast cancer (BC) patients and healthy controls (HCs).
• To discover novel protein biomarkers for potential BC diagnosis.
• To validate potential biomarkers using independent datasets and laboratory methods.

Main Methods:

• Mass spectrometry was used to analyze protein expression in sEVs from BC patients and HCs.
• Differential protein expression analysis was performed across two independent cohorts.
• Validation involved online gene expression data, Western blot, and ELISA.

Main Results:

• Nine proteins were found to be significantly upregulated in BC-derived sEVs compared to controls.
• The protein OIT3 was identified as upregulated in BC tissue versus HC tissue.
• These findings highlight OIT3's potential as a novel BC biomarker.

Conclusions:

• This study advances the understanding of protein content within sEVs.
• Upregulated proteins in sEVs, like OIT3, show potential for developing new BC diagnostic tools.
• sEVs represent a promising platform for future cancer biomarker discovery and diagnostics.